Results 111 to 120 of about 67,161 (291)

Evidence based practice: What is it? and why does it matter [PDF]

open access: yes, 1999
The terms `evidence' and 'evidence-based practice' are now common place in health care literature. Government reports make increasing use of these terms and seek to encourage all health professionals to base their practice on sound evidence (Department ...
Hundley, Vanora
core  

Cardiogenic cerebral infarction after Takotsubo cardiomyopathy in a patient with catatonia: A case report

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Background Takotsubo cardiomyopathy (TTC) is a transient cardiac condition often triggered by an emotional or physical stress. TTC usually has a benign clinical course with full recovery. However, in rare cases, TTC is complicated by cardiogenic shock, left ventricular rupture, or ventricular thrombus.
Masaki Fujiwara   +4 more
wiley   +1 more source

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? [PDF]

open access: bronze, 1986
Frank Vermeer   +9 more
openalex   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19 [PDF]

open access: gold, 2020
Gayatri Setia   +9 more
openalex   +1 more source

Simultaneous Intracranial and Spinal Hemorrhage Following Tenecteplase Thrombolysis for ST‐Elevation Myocardial Infarction: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Central nervous system (CNS) hemorrhage is a serious complication of intravenous thrombolysis. Tenecteplase, a fibrin‐specific thrombolytic agent, has a lower risk of hemorrhage than other agents. We report the first documented case of simultaneous intracranial and spinal hemorrhage following intravenous administration of tenecteplase.
Thamalee Palliyaguru   +4 more
wiley   +1 more source

Efficacy and Safety of Butylphthalide for Neurological Recovery After Cardiac Arrest: A Pilot Randomized Controlled Trial

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Butylphthalide (NBP) is a neuroprotective agent that ameliorates cerebral ischemia‐hypoxia and reperfusion injury. However, evidence regarding whether NBP can improve neurological prognosis in patients with cardiac arrest (CA) remains limited.
Xingsheng Wang   +8 more
wiley   +1 more source

A Comparison of Thrombolytic Therapy and Primary Angioplasty in Patients with Acute Myocardial Infarction [PDF]

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Background and Objective: The standard treatment for patients with acute myocardial infarction is to reestablish blood flow in the blocked vessels, which is possible through angioplasty and thrombolytic therapy. However, even in developed countries, some
MS Ramezani   +5 more
doaj  

Thrombolytic therapy [PDF]

open access: yesCanadian Anaesthetists’ Society Journal, 1985
A, Bailey, J C, Lydon, F J, Spielman
openaire   +2 more sources

Mitochondrial Intercellular Transfer via Platelets After Physical Training Exerts Neuro‐Glial Protection Against Cerebral Ischemia

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Treadmill training protects against white matter injury and reduces cerebral infarction. Muscle‐derived mitochondrial transfer via platelets is promoted by treadmill training. Platelet transfusion emerges as a potential low‐risk therapeutic strategy for sequelae and vascular dementia.
Toshiki Inaba   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy